Conference Coverage

Interrupting Oral Anticoagulation in AF Carries High Thromboembolic Cost

Neurology Reviews. 2016 December;24(12):44

 

Suggested Reading

Giugliano RP, Ruff CT, Braumwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093-2104.

Pages

Recommended Reading

Hormonal Contraceptives: Risk or Benefit in Migraine?
MDedge Neurology
14% of ASCVD patients need a PCSK9 inhibitor to reach LDL goal
MDedge Neurology
Can carotid interventions affect cognitive function?
MDedge Neurology
CEA risk models fit for an app
MDedge Neurology
Carotid stenting tied to cardiovascular events in real-world study
MDedge Neurology
Is regional anesthesia safer in CEA?
MDedge Neurology
Scoring formula consolidates stroke, bleeding risk in atrial fib patients
MDedge Neurology
VIDEO: Rivaroxaban gives safer protection to atrial fib patients post PCI
MDedge Neurology
Cardiac rehab also slashes stroke risk
MDedge Neurology
Scoring Formula Consolidates Stroke and Bleeding Risk in Patients With Atrial Fibrillation
MDedge Neurology